FundedIQ

Funded Biotechnology Research Startups

Among the 24 most recent funded biotechnology research rounds shown, the largest disclosed amount is Expedition Medicines’ $50M (2025-10-22).

Among the 24 most recent funded biotechnology research rounds shown, the largest disclosed amount is Expedition Medicines’ $50M (2025-10-22). That $50M figure sits at the top of the list but does not stand alone: Avidicure also shows $50M (2025-04-24), while the next-largest disclosed amounts are in the $30M–$23M band (Sensorium Therapeutics’ $30M on 2022-11-08; Concerto Biosciences’ $23M on 2022-11-02; Living Carbon’s $21M on 2023-01-17).

Geographically, the United Kingdom appears multiple times (Prima Mente in London, 2026-04-16; Polari Group in London, 2024-06-27; plus HAON Life Sciences in Dublin, Ireland), but the list is not dominated by one single city. Temporally, most disclosed rounds cluster in bursts rather than a steady cadence, with notable activity around 2025 (multiple entries from April through October 2025, including Avidicure, HAON Life Sciences, and Expedition Medicines) and smaller late-2022 concentrations (several 2022-11 rounds, including Sensorium Therapeutics, Rebus Biosystems, and Concerto Biosciences). Stage labeling is mixed: there are 6 “Series Unknown” entries and 2 rounds marked “undisclosed” (Prima Mente on 2026-04-16; TeraCyte Analytics on 2023-06-06; and Empatica on 2022-11-22). The disclosed amounts in the list range down to Walela’s $50K (2022-11-01).

Most recent rounds

24 shown
F
FibroBiologics
Houston, United States · Biotechnology Research
Series Unknown · Jun 2026
$3.0M
F
Foamlab
South Holland, United States · Biotechnology Research
Seed · Apr 2026
$3.5M
P
Prima Mente
London, United Kingdom · Biotechnology Research
Seed · Apr 2026
Undisclosed
I
Intrinsic Foundries
Boston, United States · Biotechnology Research
Seed · Feb 2026
$1.3M
A
Auxilium Biotechnologies
San Diego, United States · Biotechnology Research
Series Unknown · Oct 2025
$3.5M
E
Expedition Medicines
Cambridge, United States · Biotechnology Research
Series A · Oct 2025
$50M
N
Native Labs
London, United Kingdom · Biotechnology Research
Pre-Seed · May 2025
$200k
A
Avidicure
South Holland, United States · Biotechnology Research
Seed · Apr 2025
$50M
H
HAON Life Sciences
Dublin, Ireland · Biotechnology Research
Series Unknown · Apr 2025
$12M
P
Polari Group
London, United Kingdom · Biotechnology Research
Pre-Seed · Jun 2024
$540k
O
Orange Grove Bio
Cincinnati, United States · Biotechnology Research
Series Unknown · Apr 2024
$5.1M
V
Verschuren Centre
Canada, United States · Biotechnology Research
Series Unknown · Sep 2023
$1.0M
F
Fresh Inset
Torun, Poland · Biotechnology Research
Series B · Aug 2023
$3.0M
T
TeraCyte Analytics
Caesarea, Israel · Biotechnology Research
Series Unknown · Jun 2023
Undisclosed
N
Nanite
Boston, United States · Biotechnology Research
Seed · Feb 2023
$6.0M
L
Living Carbon
San Francisco, United States · Biotechnology Research
Series A · Jan 2023
$21M
L
Love Lifesciences
Overland Park, United States · Biotechnology Research
Series Unknown · Nov 2022
$280k
E
Empatica
Boston, United States · Biotechnology Research
Series B · Nov 2022
Undisclosed
C
Cybele Microbiome
San Diego, United States · Biotechnology Research
Series Unknown · Nov 2022
$890k
S
Sensorium Therapeutics
Boston, United States · Biotechnology Research
Series A · Nov 2022
$30M
T
The Citizen Science Lab
Pittsburgh, United States · Biotechnology Research
Series Unknown · Nov 2022
$500k
R
Rebus Biosystems
Santa Clara, United States · Biotechnology Research
Series Unknown · Nov 2022
$18M
C
Concerto Biosciences
Cambridge, United States · Biotechnology Research
Series A · Nov 2022
$23M
W
Walela
Chicago, United States · Biotechnology Research
Series Unknown · Nov 2022
$50k

Related listings

Frequently asked

What’s the largest disclosed round in this biotech research slice, and how does it compare to the next-largest disclosed amounts?

Expedition Medicines reported the largest disclosed amount at $50M on 2025-10-22, matching Avidicure’s $50M on 2025-04-24. The next-largest disclosed amounts are materially lower, clustering around $30M–$23M (Sensorium Therapeutics $30M on 2022-11-08; Concerto Biosciences $23M on 2022-11-02; Living Carbon $21M on 2023-01-17).

Are there date-window clusters where multiple rounds land close together?

Yes. Several rounds concentrate in late 2022 around 2022-11-08 (Sensorium Therapeutics $30M on 2022-11-08; The Citizen Science Lab $500K on 2022-11-08; Empatica is also in the same day category with an undisclosed amount on 2022-11-22 but a different date), and 2025 shows multiple entries from April through October (Avidicure 2025-04-24 at $50M; HAON Life Sciences 2025-04-09 at $12M; Expedition Medicines 2025-10-22 at $50M).

Is any geography over-represented relative to the rest of the list?

The United Kingdom shows repeated entries, with two companies explicitly located in London (Prima Mente, 2026-04-16, undisclosed; Polari Group, 2024-06-27, $540K). Beyond that, locations are distributed across the US (e.g., Boston appears multiple times with Intrinsic Foundries on 2026-02-17 at $1M and Nanite on 2023-02-15 at $6M) and other countries like Ireland (HAON Life Sciences in Dublin on 2025-04-09 at $12M).

How dominant is “Series Unknown” versus disclosed stage labels in this set?

Stage labels are mixed: 6 of the 24 rows are marked “Series Unknown” (e.g., FibroBiologics on 2026-06-29 at $3M; Auxilium Biotechnologies on 2025-10-23 at $4M; Orange Grove Bio on 2024-04-24 at $5M). In addition, 3 rounds are marked “undisclosed” amounts (Prima Mente 2026-04-16; TeraCyte Analytics 2023-06-06; Empatica 2022-11-22).

What outliers stand out on the disclosed-amount scale?

The top of the disclosed range is anchored by $50M rounds (Expedition Medicines 2025-10-22; Avidicure 2025-04-24). On the low end, Walela’s $50K on 2022-11-01 is far below the rest of the disclosed amounts (with the next-small disclosed example being Native Labs’ $200K on 2025-05-21).

Which entry is the most recent in the list, and how does it differ from the size outliers?

The most recent row is FibroBiologics, dated 2026-06-29 with $3M disclosed. That sits well below the disclosed $50M peak rounds (Avidicure 2025-04-24 and Expedition Medicines 2025-10-22) and below other high-disclosed entries like Sensorium Therapeutics’ $30M on 2022-11-08.

Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.